Lieselotte Verlinden

1 ta ish

Institute of Nuclear Physics

1. 50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209

   Graham R. Foster, Christophe Hézode, J.‐P. Bronowicki +7

   MaqolaHepatitis C virus researchJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/2009.article.000028